Perinatal exposure to morphine: Reactive changes in the brain after 6-hydroxydopamine

European Journal of Pharmacology

Volumn 303, Issue 1-2, 1996, Pages 21-26

  Gorio, Alfredo ^a,b   Vergani, Letizia ^a   Malosio, Maria Luisa ^a   Lesma, Elena ^a   Di Giulio, Anna Maria ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Lab Res Pharmacol Neurodeg D   (Italy)

Author keywords

Neuronal plasticity; Opiate receptor; Pruning effect; Synapsin I

Indexed keywords

BRAIN MONOAMINE; DOPAMINE; MARKER; MESSENGER RNA; MORPHINE; NORADRENALIN; OXIDOPAMINE; SEROTONIN; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DENTATE GYRUS; DRUG EXPOSURE; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MEDULLA OBLONGATA; MESENCEPHALON; NEWBORN; NONHUMAN; OLFACTORY BULB; ORAL DRUG ADMINISTRATION; PERINATAL PERIOD; PLASTICITY; PONS; PRIORITY JOURNAL; RAT;

EID: 0029955353     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00054-4     Document Type: Article

References (42)

1. Angulo, J.A., L.G. Davis, B.A. Burkhart and G.R. Christoph, 1986, Reduction of striatal dopaminergic neurotransmission elevates striatal proenkephalin mRNA, Eur. J. Pharmacol. 130, 341.
2. Aoki, F. and S. Nakamura, 1991, The mode of axonal regeneration of locus coeruleus neurons in the lateral geniculate nucleus following neonatal 6-hydroxydopamine treatment, Exp. Neurol. 112, 284.
3. De Saint Blanquat, G., Y. Lamboeuf and P. Fritsch, 1987, Detection of catecholamines in biological tissues by liquid chromatography with coulometric detection, J. Chromatogr. 415, 388.
4. Di Giulio, A.M., B. Tenconi, A. Mannavola, P. Mantegazza, A. Schiav inato and A. Gorio, 1987, Spinal cord interneuron degenerative atrophy caused by peripheral nerve lesions is prevented by serotonin depletion, J. Neurosci. Res. 18, 443.
5. Di Giulio, A.M., B. Tenconi, R. La Croix, P. Mantegazza, M.P. Abbracchio, F. Cattabeni and A. Gorio, 1989, Denervation and hypertnnervation in the nervous system of diabetic animals. II. Monoaminergic and peptidergic alterations in the diabetic encephalopathy, J. Neurosci. Res. 24, 362.
6. Di Giulio, A.M., B. Tenconi, M.L. Malosio, L. Vergani, A. Bertelli and A. Gorio, 1995, Exposure to perinatal morphine. I. Effects on synapsin I and neurotransmitter systems in the brain, J. Neurosci. Res. 42, 479.
7. Germani, E., E. Lesma, S. De Biasi, A.M. Di Giulio, A. Bertelli and A. Gorio, 1995, Exposure to perinatal morphine. II. Changes in cortical plasticity, J. Neurosci. Res. 42, 829.
8. Gorio, A., A.M. Di Giulio, E. Germani, C. Bendotti, A. Bertelli and P. Mantegazza, 1993, Perinatal morphine treatment inhibits pruning effect and regeneration of serotoninergic pathways following neonatal 5,7-HT lesions. J. Neurosci. Res. 34, 462.
9. Gorio, A., M.L. Malosio, L. Vergani and A.M. Di Giulio, 1996, Exposure to perinatal morphine promotes developmental changes in rat striaturn. Int. J. Dev. Neurosci. (in press).
10. Govritapong, P., X. Zhang, H.H. Loh and N.M. Lee, 1993, Transfection of NG108-15 cells with antisense opioid-binding cell adhesion molecule cDNA alters opioid receptor-G-protein interaction, J. Biol. Chem. 268, 18280.
11. Gustafson, E.L. and R.Y. Moore, 1987, Noradrenaline neuron plasticity in developing rat brain: effects of neonatal 6-hydroxydopamine demonstrated by dopamine-B-hydroxylase immunocytochemistry, Dev. Brain Res. 37, 143.
12. Hammer, R.P., A.A. Ricalde and J.V. Seatrix, 1989, Effects of opiates on brain development, Neurotoxicology 10, 475.
13. Hui, F.W., E.K. Krikum and A.A. Smith, 1978, Inhibition by d,l-methadone of RNA and protein synthesis in neonatal mice: antagonism by naloxone or naltrexone. Eur. J. Pharmacol. 49, 87.
14. Isayama, T., P.J. McLaughlin and J.S. Zagon, 1991, Endogenous opioids regulate cell proliferation in the retina of developing rat, Brain Res. 544, 79.
15. Kalyuzhny, A., N.M. Lee and R. Eide, 1995, An opioid binding protein is specifically down-regulated by chronic morphine treatment in dorsal root and trigeminal ganglia, Neuroscience 66, 943.
16. Kent, J., C. Pert and M. Herkenham, 1982, Ontogeny of opiate and related peptides in the ens and pituitary: an immunocytochemical study. Life Sci. 33, Suppl. 61.
17. Kornblum, H.I., S.E. Loughlin and F.M. Leslie, 1987, Effects of morphine on DNA synthesis in neonatal rat brain, Dev. Brain Res. 31, 45.
18. Lane, C.M., R. Elde, H.H. Loh and N.M. Lee, 1992, Regulation of an opioid-binding protein in NG108-15 cells parallels regulation of delta-opioid receptors, Proc. Natl. Acad. Sci. USA 89, 11234.
19. Loughlin, S., T. Massamiri, H. Kornblum and F. Leslie, 1985, Postnatal development of opioid systems in rat brain. Neuropeptides 5, 469.
20. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 93, 262.
21. Luthman, J., B. Bolioli, T. Tsutsumi, A. Verhofstad and G. Jonsson, 1987, Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in the neonatal rat, Brain Res. Bull. 19, 269.
22. 5)enkephalin as a binding ligand, Eur. J. Pharmacol. 128, 287.
23. Oke, A., R. Keller and R.N. Adams, 1978, Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment, Brain Res. 148, 245.
24. Ricalde, A.A. and R.P. Hammer, 1990, Perinatal opiate treatment delays growth of cortical dendrites, Neurosci. Lett. 115, 137.
25. Roy, S., Y.X. Zhu, N.M. Lee and H.H. Loh, 1988a, Different molecular weight forms of opioid receptors revealed by polyclonal antibodies, Biochem. Biophys. Res. Commun. 150, 237.
26. Roy, S., Y.X. Zhu, H.H. Lob and N.M. Lee, 1988b, A monoclonal antibody that inhibitsopioid binding to rat brain membranes, Biochem. Biophys. Res. Commun. 154, 688.
27. Sachs, C. and G. Jonsson, 1975, Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny, Brain Res. 99, 277.
28. Schneider, G.E., 1973, Early lesions of superior colliculus: factors affecting the formation of abnormal retinal projections, Brain Behav. Evol. 8, 78.
29. Schofield, P.R., K.C. McFarland, J.S. Hayflick, J.N. Wilcox, T.N. Cho, S. Roy, N.M. Lee, H.H. Loh and P.H. Seeburg, 1989, Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact, EMBO J. 8, 489.
30. Seatrix, J.W. and R.P. Hammer, 1993, Effects of morphine on neuronal development in the rat cerebral cortex, Brain Res. Bull. 30, 523.
31. Sivam, S.P., G.R. Breese, T.C. Napier, R.A. Mueller and J.-S. Hong, 1986, Dopaminergic regulation of proenkephalin-A gene expression in the basal ganglia, NIDA Res. Monogr. 75, 389.
32. Stien-Martin, A. and K.F. Hauser, 1990, Opioid-dependent growth of glial cultures; suppression of DNA synthesis by Met-enkephalin, Life Sci. 46, 91.
33. Tao, P.-L., C.-R. Lee, P.-Y. Law and H.H. Loh, 1993, The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats, Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 504.
34. Tenconi, B., M.L. Donadoni, C. Finco, E. Germani, M.L. Malosio, A.M. Di Giulio, P. Mantegazza and A. Gorio, 1992, Perinatal morphine exposure alters peptidergic development in the striatum, Int. J. Dev. Neurosci. 10, 517.
35. Tenconi, B., E. Lesma, A.M. Di Giulio, A. Bertelli and A. Gorio, 1996, Opiate exposure affects PC12 neurite formation, Dev. Brain Res. (in press).
36. Vathy, I.U., A.M. Etgen and R.J. Barfield, 1985, Effects of prenatal exposure to morphine on the development of sexual behaviour in rats, Pharmacol. Biochem. Behav. 22, 227.
37. Wilson, S.G., M.D. Desmond and W.M. Verniaud, 1973, Early development of infants of heroin addicted mothers, Am. J. Dis. Child 126, 457.
38. Wilson, S.G., R.M. McCreary, J. Kean and J.C. Baxter, 1979, The development of preschool children of heroin-addicted mothers: a controlled study, Pediatrics 63, 135.
39. Wisden, W., B.J. Morris and S.P. Hunt, 1991, In situ hybridization with synthetic DNA probes, in: Molecular Neurobiology - A Practical Approach, eds. Chad and Wheal (IRL Press, Oxford) p. 205.
40. Zagon, I.S. and P.J. McLaughlin, 1983a, Naltrexone modulates growth in infant rats, Life Sci. 33, 2449.
41. Zagon, I.S. and P.J. McLaughlin, 1983b, Increased brain size and cellular content in infant rats treated with an opiate antagonist, Science 221, 1179.
42. Zagon, I.S. and P.J. McLaughlin, 1984, Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth. Life Sci. 35, 1957.